Catalyst Pharmaceuticals, Inc. (CPRX)
$31.49+0.00%Close
BUYBULL · day 72
Key stats
- Market cap
- $3.9B
- Beta
- 0.74
- P/E (TTM)
- 17.49
- 1W
- +0.00%
- 1M
- +0.35%
- vs SPY 1W
- -0.42%
- vs SPY 1M
- -1.71%
Industry peers
FMP comparable companies · ranked by market cap
- EXELBUYExelixis, Inc.$15.0BBULLQ 10$59.86-0.07%
- MDGLSELLMadrigal Pharmaceuticals, Inc.$10.9BBEARQ 16$471.75-0.97%
- AXSMSELLAxsome Therapeutics, Inc.$8.7BCRISISQ 34$168.35-1.40%
- VKTXSELLViking Therapeutics, Inc.$3.3BCRISISQ 22$28.51-0.60%
- AMLXSELLAmylyx Pharmaceuticals, Inc.$3.1BRECOVERYQ 7$28.14-2.35%
- VSTMBUYVerastem, Inc.$736MRECOVERYQ 4$8.38-1.55%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on CPRX?
- LOPJLB’s latest quantitative signal on Catalyst Pharmaceuticals, Inc. (CPRX) is BUY in a BULL regime. Signals are updated daily.
- What market regime is CPRX in?
- Catalyst Pharmaceuticals, Inc. (CPRX) is currently classified in the BULL HMM market regime on LOPJLB.
- What does Catalyst Pharmaceuticals, Inc. (CPRX) do?
- Catalyst Pharmaceuticals, Inc., founded in 2002 and based in Coral Gables, Florida, operates as a commercial-stage biopharmaceutical enterprise. This company is dedicated to discovering, developing, and marketing therapeutic solutions for individuals in the United States who are afflicted with uncommon, severe, and long-term neuromuscular and neurological disorders. Among its key offerings is F…